Company could have around 4.5m to distribute to shareholders
The board of Dublin-listed Merrion Pharmaceuticals has proposed that the company be wound up, with its remaining funds distributed to shareholders.
Following the sale of its intellectual property assets to drug giant Novo Nordisk and changes to the licence agreements between the two companies last year, Merrion became an investment company with a focus on the healthcare sector.
In a statement today, however, Merrion said its board had looked at a number of investment proposals, none of which were thought “sufficiently compelling” to recommend to shareholders.
The board said a statutory declaration of solvency for the company indicate…
Read the full article at: https://www.businesspost.ie/merrion-pharmaceuticals-announces-liquidation-plan/
